1
|
Buyukbayram ME, Hannarici Z, Turhan A, Caglar AA, Esdur PÇ, Bilici M, Tekin SB, Erdemci B. A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR). BMC Cancer 2024; 24:626. [PMID: 38783223 DOI: 10.1186/s12885-024-12347-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Accepted: 05/06/2024] [Indexed: 05/25/2024] Open
Abstract
BACKGROUND Cervical cancer is a tumor with high morbidity and mortality. The importance of inflammatory and metabolic parameters affecting progression-free survival (PFS) and overall survival (OS) has been investigated more intensively recently. We aimed to investigate the effect of glucose/c-reactive protein (CRP) ratio [GCR], which shows these two parameters together, on PFS in cervical cancer. METHODS We retrospectively included 90 patients with adenocarcinoma and squamous cell carcinoma of the cervix. The effects of clinical variables, inflammatory and glycemic parameters on PFS and OS were analyzed by Kaplan-Meier method. The data were compared with the healthy control group of 90 individuals using the independent t test. The effect of parameters on mortality was analyzed using ROC curves and cut off values were determined. RESULTS Glucose, CRP, CRP/lymphocyte ratio (CLR) and GCR were statistically significant in predicting mortality (p < 0.05). Disease stage, glucose, CRP, CLR and GCR were associated with overall survival. CRP, CLR and GCR were associated with progression-free survival (p < 0.05). In multivariate analysis, GCR was prognostic for PFS (p = 0.025). GCR was statistically significant while compared with the patient and healthy control group (p < 0.001). CONCLUSION In cervical cancer, GCR rate was found to be prognostic independent of stage. Higher GCR rate was associated with longer PFS duration.
Collapse
Affiliation(s)
| | - Zekeriya Hannarici
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | - Aykut Turhan
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | | | - Pınar Çoban Esdur
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | - Mehmet Bilici
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | - Salim Basol Tekin
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | - Burak Erdemci
- Department of Radiation Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| |
Collapse
|
2
|
Celik Z, Baygutalp NK, Kilic AF, Tekin SB, Bakan E, Gul MA, Yuce N. Serum irisin levels in colorectal cancer patients. Eur Rev Med Pharmacol Sci 2023; 27:1474-1479. [PMID: 36876687 DOI: 10.26355/eurrev_202302_31387] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 03/07/2023]
Abstract
OBJECTIVE There are limited studies investigating the role of irisin in colorectal cancer, and the results are diverse. The role of irisin in colorectal cancer patients was investigated in this study. PATIENTS AND METHODS This cross-sectional study included 53 patients diagnosed with colorectal cancer (CRC) and 87 healthy volunteers. Serum irisin, glucose, insulin, C-peptide, and whole blood hemoglobin A1c (HbA1c) levels were measured in venous blood samples taken from patients and the control group. RESULTS The mean serum irisin levels were significantly lower in the patient group (23.97 ± 16.94 ng/mL) than in the control group (32.71 ± 17.26 ng/mL) (p = 0.004). Serum glucose levels were 96.58 ± 15.12 mg/dL in the patient group and 81.91 ± 11.24 mg/dL in the control group. Serum glucose levels were significantly higher in the patient group than in the control group (p < 0.01). In the patient group, there was no statistically significant difference between metastasis (+) patients and metastasis (-) patients in terms of serum irisin levels (27.53 ± 18.48 ng/mL and 21.23 ± 15.43 ng/mL, respectively; p = 0.182). CONCLUSIONS Our study has provided new insights into the potential role of irisin in CRC. However, further studies, including in vitro, in vivo, and larger patient groups, are necessary to fully understand the potential of irisin as a biomarker or therapeutic target for CRC and other diseases.
Collapse
Affiliation(s)
- Z Celik
- Department of Biomaterials and Tissue Engineering, Institute of Science, Harran University, Şanlıurfa, Turkey.
| | | | | | | | | | | | | |
Collapse
|
3
|
Bozgeyik B, Tekin SB, Mert A. Can neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratios be useful to the diagnosis of aseptic loosening after total knee arthroplasty? BRATISL MED J 2021; 122:880-883. [PMID: 34904850 DOI: 10.4149/bll_2021_143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND The aim of this study is to determine the role of hematological parameters - neutrophil/lymphocyte, platelet/lymphocyte, and monocyte/lymphocyte ratios - in the diagnosis of aseptic loosening after total knee arthroplasty. METHODS This study retrospectively analyzed the data of 244 patients who had primary total knee arthroplasty and 66 patients with aseptic loosening developed after total knee arthroplasty. The white blood cell counts, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, monocyte/lymphocyte ratio and c-reactive protein levels in both groups were determined using the results of venous blood samples collected during preoperative preparation and compared between the groups. RESULTS Our study findings reveal that the monocyte/lymphocyte ratio of the group with aseptic loosening was statistically significantly different from that of the patient group who had primary total knee arthroplasty (p=0.02). Furthermore, although c-reactive protein levels are not high enough to suggest systemic inflammation, the difference between the groups is statistically significant (p=0.01). CONCLUSIONS No hematological parameter that could be used in the diagnosis of aseptic loosening has been defined in the literature so far. This study demonstrated that the monocyte/lymphocyte ratio could be a helpful parameter in the diagnosis of aseptic loosening (Tab. 1, Fig. 1, Ref. 28).
Collapse
|
4
|
Salih Akarca U, Unsal B, Sezgin O, Yalcin K, Akdogan M, Gonen C, Gunduz F, Ozenirler S, Sonsuz A, Dincer D, Basol Tekin S, Yucel I, Akbulut H, Alkım C, Ozyilkan O, Baygul A, Cevik ZM, Idilman R. Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study. Turk J Gastroenterol 2021; 32:1019-1028. [PMID: 34876392 PMCID: PMC8975510 DOI: 10.5152/tjg.2021.201171] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
AIMS To evaluate patient profile for epidemiological and clinicopathological characteristics and potential risk/prognostic factors in newly diagnosed hepatocellular carcinoma (HCC) patients across Turkey. METHODS A total of 547 patients (mean (SD) age 62.6 (10.3) years, 81.9% were males) were included in this registry study. Data on patient characteristics, etiologies of HCC, laboratory values, and tumor characteristics and stages were recorded at study enrollment. RESULTS HBV infection (68.2%) was the leading etiology, followed by HCV infection (17.2%), HDV infection (5.5%), alcohol (6.4%), and NAFLD (3.5%), as the major etiologies. Considering that 51.6% of the patients had >5 cm HCC, 44% were Child-Pugh B/C and 57% were BCLC B-D, it appears that a significant group of HCC patients were diagnosed at advanced stages. Of 540 patients, 271 (50.2%) were referred or applied with the diagnosis of HCC. Patients with HCC at presentation had larger tumor size (median (min-max) 6.6 (0-30) vs. 4.8 (0-90) cm, P < .001) and more advanced BCLC stage (Stage C-D in 40.8% vs. 26.4%, respectively, P = .005), compared to patients who were diagnosed during follow-up. CONCLUSIONS Our findings revealed that HBV infection was the leading etiology and a moderate-to-advanced disease was evident in more than half of patients at the time of diagnosis. HCC patients diagnosed at follow-up had smaller tumor size and earlier BCLC stage.
Collapse
Affiliation(s)
- Ulus Salih Akarca
- Department of Gastroenterology, Ege University Faculty of Medicine, Izmir, Turkey
- Corresponding author: Ulus Salih Akarca, e-mail:
| | - Belkis Unsal
- Clinic of Gastroenterology, Izmir Ataturk Training and Research Hospital, Izmir, Turkey
| | - Orhan Sezgin
- Department of Gastroenterology, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Kendal Yalcin
- Department of Gastroenterology, Dicle University Faculty of Medicine, Diyarbakir, Turkey
| | - Meral Akdogan
- Clinic of Gastroenterology, Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey
| | - Can Gonen
- Clinic of Gastroenterology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
| | - Feyza Gunduz
- Clinic of Gastroenterology, Marmara University Faculty of Medicine Pendik Training and Research Hospital, Istanbul, Turkey
| | - Seren Ozenirler
- Department of Gastroenterology, Gazi University Faculty of Medicine, Ankara, Turkey
| | - Abdullah Sonsuz
- Department of Gastroenterology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey
| | - Dinc Dincer
- Department of Gastroenterology, Akdeniz University Faculty of Medicine, Antalya, Turkey
| | - Salim Basol Tekin
- Department of Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | - Idris Yucel
- Department of Oncology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey
| | - Hakan Akbulut
- Department of Oncology, Ankara University Faculty of Medicine, Ankara, Turkey
| | - Canan Alkım
- Clinic of Gastroenterology, Sisli Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Ozgur Ozyilkan
- Department of Oncology, Adana Baskent University Faculty of Medicine, Adana, Turkey
| | - Arzu Baygul
- Department of Biostatistics, Koc University School of Medicine, Istanbul, Turkey
| | | | - Ramazan Idilman
- Department of Gastroenterology, Ankara University Faculty of Medicine, Turkey
| |
Collapse
|
5
|
Yilmaz A, Mirili C, Bilici M, Tekin SB. A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII). J BUON 2019; 24:2127-2135. [PMID: 31786885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
PURPOSE Systemic inflammation and immune response are associated with tumors'prognosis. However, there is little information about inflammatory indexes in patients with gastrointestinal stromal tumor (GIST). In this study, we aimed to determine the prognostic significance of inflammation indexes such as neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII), prognostic nutritional index (PNI) and Glasgow prognostic score (GPS) in GIST patients. METHODS Forty-five patients diagnosed with GIST between 2003 and 2018 were included in the study. The effects of NLR, SII, PNI and GPS on progression-free survival (PFS) and overall survival (OS) estimated based on clinicopathological and laboratory data were evaluated by Kaplan-Meier and Cox regression analysis. RESULTS The optimal cut-off values for NLR, SII and PNI were 2.54, 940, and 37.5, respectively. Low SII and higher PNI values were associated with longer PFS (p=0.041, p=0.018, respectively). In terms of OS, patients with high NLR, high SII and low PNI had a shorter lifespan. In multivariate analysis, only SII was found to be independent prognostic factor. CONCLUSION In cases with GIST, SII may predict recurrence and survival.
Collapse
Affiliation(s)
- Ali Yilmaz
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | | | | | | |
Collapse
|
6
|
Simsek M, Bilici M, Tekin SB. Creatinine kinase elevation and peripheral neuropathy during nivolumab treatment of a patient with metastatic renal cell carcinoma. Indian J Cancer 2019; 55:413-414. [PMID: 30829281 DOI: 10.4103/ijc.ijc_151_18] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
We report elevation of creatinine kinase (CK), which is an uncommon adverse event related to treatment with nivolumab. Nivolumab is a monoclonal antibody against programmed cell death-1 and an effective agent in metastatic renal cell carcinoma (RCCa). Here, we report a case of 58 year-old male receiving nivolumab as fourth-line treatment for metastatic RCCa. The patient was admitted to our clinic with pelvic pain and weakness in his legs. Elevated CK level was noted and he was hospitalized. About 1 mg/kg methylprednisolone was initiated and nivolumab was discontinued. On the second day of his hospitalization, left facial palsy occurred. After his neuropathy improved and CK level normalized, the patient was discharged. Neurological immune-related adverse events are very rare with nivolumab but can be serious.
Collapse
Affiliation(s)
- Melih Simsek
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | - Mehmet Bilici
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| | - Salim Basol Tekin
- Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey
| |
Collapse
|
7
|
Yildirim N, Simsek M, Aldemir MN, Bilici M, Tekin SB. Relationship between 18-FDG-PET/CT and Clinicopathological Features and Pathological Responses in Patients with Locally Advanced Breast Cancers. Eurasian J Med 2019; 51:154-159. [PMID: 31258356 DOI: 10.5152/eurasianjmed.2018.18036] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Objective We investigated the relationship between the maximum standardized uptake value (SUVmax) of whole-body positron emission tomography/computed tomography (PET/CT) performed before treatment and the demographical and histopathological features in locally advanced breast cancer (LABC), as well as the role of PET/CT in the evaluation of pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). Materials and Methods Fifty-one LABC patients who received NAC in our center between 2011 and 2015 were retrospectively analyzed. Basal PET/CT was performed in all the patients before NAC. The SUVmax levels and demographical and histopathological results were compared. The relationship between the SUVmax values after NAC and pathological responses were evaluated. Results The mean age of the patients was 49 (32-69) years. PET/CT performed after NAC showed complete response in 20 patients (39.2%), partial response in 28 patients (54.9%), stable disease in 2 patients (3.9%), and progressive disease in 1 patient (2%). There was no significant difference between the mean SUVmax values of the patients according to age (>50 and ≤50 years), menopausal status, tumor localization, clinical stage, and grade. The mean SUVmax value was higher in the triple-negative group than those in the HER2 positive and luminal groups. There was a significant difference in the SUVmax values between the group that achieved pCR after NAC and the group that could not achieve pCR (SUVmax value for breast 2.92 vs. 0.30; p=0.01; SUVmax value for axilla 1.5 vs. 0.0, p=0.02). Conclusion The SUVmax values are independent of demographical features. There was a significant relationship between the pCR and SUVmax values after NAC. PET/CT could be useful in the evaluation of patients to predict the biological characteristics of tumors.
Collapse
Affiliation(s)
- Nilgun Yildirim
- Department of Medical Oncology, Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey
| | - Melih Simsek
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| | - Mehmet Naci Aldemir
- Department of Medical Oncology, Erzincan University School of Medicine, Erzincan, Turkey
| | - Mehmet Bilici
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| | - Salim Basol Tekin
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| |
Collapse
|
8
|
Mirili C, Yılmaz A, Demirkan S, Bilici M, Basol Tekin S. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. Int J Clin Oncol 2019; 24:1301-1310. [DOI: 10.1007/s10147-019-01461-7] [Citation(s) in RCA: 43] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2019] [Accepted: 04/26/2019] [Indexed: 12/17/2022]
|
9
|
Abstract
Objective Primary gastrointestinal non-hodgkin lymphomas (PGI-NHL) are uncommon diseases with treatment modalities including chemotherapy, surgery, and radiotherapy. Our aim is to analyze the demographic and clinical features and treatment results of PGI-NHL. Materials and Methods 286 patients diagnosed with lymphoma who referred to Ataturk University Medical Faculty Hospital between July 2001 and April 2014 were surveyed retrospectively and 22 (7.6%) PGI-NHL cases whose primary lesions were in gastrointestinal system were included. Results Mean age was 47 (min.25-max.77) and 14 (63.6%) of them were men. The origin was determined as small intestines (50%), stomach (31.8%) and colon (18.2%), respectively. The most common complaint and pathologic subtype were abdominal pain (68.2%) and diffuse large B cell lymphoma (86.4%), respectively. The Lugano Classification was as follows: stage 1 (18.2%), stage 2 (59.1%), and stage 4 (22.7%). Surgery and chemotherapy were administered to 40.9% of patients. Complete and partial response and disease progression were established in 72.1%, 4.5% and 13.6% of the patients, respectively. Mean survival time was 99.6±16 months. Mean overall survival time was determined significantly longer in small bowel group than gastric group (119±15 vs. 50±24 months) (p=0.039). Age, gender, Eastern Cooperative Oncology Group performance status, International Prognostic Index, stage, histological type, tumor size, LDH level, albumin level, Hemoglobin level and treatment options were not associated with survival. Conclusion Demographic and clinical characteristics of our series were similar with Middle Eastern and African countries. Optimal treatment options or prognostic factors for PGI-NHL are not clear. There is a need for randomized prospective studies including large number of patients and long follow-up period.
Collapse
Affiliation(s)
- Nilgun Yildirim
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| | - Mehmet Turkeli
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| | - Mehmet Naci Akdemir
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| | - Melih Simsek
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| | - Salim Basol Tekin
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| |
Collapse
|
10
|
Abstract
Immune checkpoint inhibitors (ICI) are monoclonal antibodies targeting cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed cell death protein-1 (PD-1), or PD-1 ligand (PD-L1). ICI are approved for the treatment of malign melanoma, non-small cell lung cancer, classical Hodgkin lymphoma, head and neck squamous cell carcinoma, urothelial carcinoma, and renal cell carcinoma. They can lead to long-term anti-tumor responses by deactivating the brake mechanism in the immune system. Ipilimumab, tremelimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab, and avelumab are examples of ICI. CTLA-4 is a brake mechanism in immune response. Ipilimumab and tremelimumab are antibodies against CTLA-4. PD-1 is another important immune checkpoint co-inhibitor receptor that is expressed by activated T cells in the peripheral tissue. As a result of blockage of the PD-1/PD-L1 pathway, local tumor-specific immune response augments, and long-term tumor control can be achieved. In recent years, ICI are approved for the treatment of various malignities. They may be responsible for specific toxicities called immune-related adverse events (irAEs). irAEs are a consequence infiltration of normal tissues by activated T lymphocytes that are responsible for autoimmunity. Corticosteroids and anti-tumor necrosis factor agents, such as infliximab and mycophenolate mofetil, are effective in the treatment of irAEs. Immune checkpoint inhibition with monoclonal antibodies against CTLA-4 and/or PD-1/PD-L1 by single agent or combination treatments became a new option in various solid tumors. However, ICI have unique adverse events, and these adverse events should be considered in any new onset clinical situation and should be managed properly. Future prospective randomized clinical trials will clarify recent questions.
Collapse
Affiliation(s)
- Melih Simsek
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| | - Salim Basol Tekin
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| | - Mehmet Bilici
- Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey
| |
Collapse
|
11
|
Aldemir MN, Turkeli M, Simsek M, Yildirim N, Bilen Y, Yetimoglu H, Bilici M, Tekin SB. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients. Asian Pac J Cancer Prev 2016; 16:5933-7. [PMID: 26320475 DOI: 10.7314/apjcp.2015.16.14.5933] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND We aimed to investigate the prognostic value of baseline neutrophil, lymphocyte, and platelet counts along with the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in local and advanced gastric cancer patients. MATERIALS AND METHODS In this retrospective cross-sectional study, a total of 103 patients with gastric cancer were included. For all, patient characteristics and overall survival (OS) times were evaluated. Data from a complete blood count test including neutrophil, lymphocyte, monocyte, white blood cell (WBC) and platelet (Plt) count, hemoglobin level (Hb) were recorded, and the NLR and PLR were obtained for every patient prior to pathological diagnosis before any treatment was applied. RESULTS Of the patients, 53 had local disease, underwent surgery and were administered adjuvant chemoradiotherapy where indicated. The remaining 50 had advanced disease and only received chemotherapy. OS time was 71.6±6 months in local gastric cancer patients group and 15±2 months in the advanced gastric cancer group. Univariate analysis demonstrated that only high platelet count (p=0.013) was associated with better OS in the local gastric cancer patients. In contrast, both low NLR (p=0.029) and low PLR (p=0.012) were associated with better OS in advanced gastric cancer patients. CONCLUSIONS This study demonstrated that NLR and PLR had no effect on prognosis in patients with local gastric cancer who underwent surgery and received adjuvant chemoradiotherapy. In advanced gastric cancer patients, both NLR and PLR had significant effects on prognosis, so they may find application as easily measured prognostic factors for such patients.
Collapse
Affiliation(s)
- Mehmet Naci Aldemir
- Department of Medical Oncology, Faculty of Medicine, Ataturk University , Erzurum, Turkey E-mail :
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Yildirim N, Turkeli M, Aldemir MN, Simsek M, Basol Tekin S. Evaluation of 22 Primary Gastrointestinal Lymphoma Patients. Eurasian J Med 2016. [DOI: 10.5152/eurasianjmed.2016.16071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
13
|
Turkeli M, Simsek M, Aldemir MN, Yildirim N, Cankaya E, Erdemci B, Bilici M, Tekin SB, Arslan S, Korkut E. Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience. Eurasian J Med 2016; 48:33-6. [PMID: 27026762 DOI: 10.5152/eurasianjmed.2015.0087] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE Our aim is to evaluate the frequency and characteristics of cancer in the population of patients with solid organ transplant who are under immunosuppressive medication. In this study we aimed to emphasize the importance of early diagnosis of cancer in solid organ transplant recipients. An aging population began to receive solid organ transplantation and survival times prolonged. But this had a cost and new problems came forward. Especially de novo cancers because of immunosuppressive therapy took notice. Risk of malignancy increases after organ transplantation and cancer incidence was about 2.3-3.1% in these patients including skin cancer, lung cancer, malign lymphoma, cervix cancer, kaposi sarcoma, and hepatobiliary cancer. MATERIALS AND METHODS The files of 328 organ transplant recipients followed from January 2004 to April 2015 at Atatürk University Medical Faculty were retrospectively reviewed. RESULTS Eight patients developed cancer (2.4%). There were six males and two females. Age at cancer diagnosis ranged from 42 to 79 years old with average of 55 years. The interval from solid organ transplantation to cancer diagnosis ranged from 6 months to 30 years. Among the patients, five were renal transplant recipients and two were liver transplant recipients. Four patients had stage IV disease, one patient stage IIIB, and three patients had stage I disease. For none of the patients a diagnosis with screening methods was used for cancer before any complaints of tumor emerged. CONCLUSION To diagnose cancer at early stages in solid organ transplant recipients, earlier and detailed cancer screening is very important. The association between diagnosis of cancer at early stages and prolonged overall survival time is well known. Detailed and careful evaluation for occult malignancies in pre-transplantation period is also important.
Collapse
Affiliation(s)
- Mehmet Turkeli
- Department of Oncology, Ataturk University School of Medicine, Erzurum, Turkey
| | - Melih Simsek
- Department of Oncology, Ataturk University School of Medicine, Erzurum, Turkey
| | - Mehmet Naci Aldemir
- Department of Oncology, Ataturk University School of Medicine, Erzurum, Turkey
| | - Nilgun Yildirim
- Department of Nephrology, Ataturk University School of Medicine, Erzurum, Turkey
| | - Erdem Cankaya
- Department of Nephrology, Ataturk University School of Medicine, Erzurum, Turkey
| | - Burak Erdemci
- Department of Radiation Oncology, Ataturk University School of Medicine, Erzurum, Turkey
| | - Mehmet Bilici
- Department of Oncology, Ataturk University School of Medicine, Erzurum, Turkey
| | - Salim Basol Tekin
- Department of Oncology, Ataturk University School of Medicine, Erzurum, Turkey
| | - Sukru Arslan
- Department of Surgery, Ataturk University School of Medicine, Erzurum, Turkey
| | - Ercan Korkut
- Department of Surgery, Ataturk University School of Medicine, Erzurum, Turkey
| |
Collapse
|
14
|
Ciltas A, Karaca M, Uncu D, Ozkan M, Aliustaoglu M, Tekin SB, Cicin I, Kocer M, Dane F, Oksuzoglu B, Isikdogan A, Ozdemir F, Elkiran ET, Karaoglu A, Yalcin B, Sevinc A, Uysal M, Boruban CEM, Benekli M, Buyukberber S. Effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e15056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | - Dogan Uncu
- Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Metin Ozkan
- Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey
| | | | | | - Irfan Cicin
- Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey
| | - Murat Kocer
- Suleyman Demirel University, Isparta, Turkey
| | - Faysal Dane
- Marmara University, Medical Oncology, Istanbul, Turkey
| | - Berna Oksuzoglu
- Ankara Oncology Research and Training Hospital Department of Medical Oncology, Ankara, Turkey
| | | | - Feyyaz Ozdemir
- Karadeniz Technical University School of Medicine, Trabzon, Turkey
| | | | | | - Bulent Yalcin
- Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
| | - Alper Sevinc
- Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey
| | - Mukremin Uysal
- Department of Medical Oncology, Afyon Kocatepe University, Afyonkarahisar, Turkey
| | - CEM Boruban
- Konya University Medical Faculty, Istanbul, Turkey
| | - Mustafa Benekli
- Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
| | - Suleyman Buyukberber
- Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
| | | |
Collapse
|
15
|
Buyukberber S, Dumanli E, Uncu D, Ozkan M, Uslu R, Dogu GG, Kara O, Abali H, Turna H, Ozturk B, Sevinc A, Uysal M, Yalcin B, Dane F, Aliustaoglu M, Cicin I, Tekin SB, Gumus M, Kilickap S, Benekli M. Turkish National Gastric Cancer Registry. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e12645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Suleyman Buyukberber
- Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
| | | | - Dogan Uncu
- Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Metin Ozkan
- Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey
| | - Ruchan Uslu
- Ege University School of Medicine, Izmir, Turkey
| | - Gamze Gokoz Dogu
- Pamukkale University Medical Faculty, Department of Medical Oncology, Kayseri, Turkey
| | - Oguz Kara
- Cukurova Univeristy Faculty of Medicine, Adana, Turkey
| | | | - Hande Turna
- Istanbul University Cerrahpasa Faculty of Medicine, Department of Oncology, Istanbul, Turkey
| | - Banu Ozturk
- Department of Medical Oncology, Gaziosmanpasa University Faculty of Medicine, Tokat, Turkey
| | - Alper Sevinc
- Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey
| | - Mukremin Uysal
- Department of Medical Oncology, Afyon Kocatepe University, Afyonkarahisar, Turkey
| | - Bulent Yalcin
- Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
| | - Faysal Dane
- Marmara University Hospital, Istanbul, Turkey
| | | | - Irfan Cicin
- Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey
| | | | - Mahmut Gumus
- Kartal Research and Training Hospital, Istanbul, Turkey
| | | | - Mustafa Benekli
- Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
| | | |
Collapse
|
16
|
Coskun U, Altundag K, Aliustaoglu M, Uncu D, Ozkan M, Cicin I, Ciltas A, Elkiran T, Kocer M, Isikdogan A, Karaoglu A, Tekin SB, Avci N, Ulas A, Oksuzoglu B, Ozdemir F, Dumanli E, Sevinc A, Kilickap S, Benekli M. Association of obesity with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e12657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Ugur Coskun
- Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
| | - Kadri Altundag
- Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey
| | - Mehmet Aliustaoglu
- Dr. Lütfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
| | - Dogan Uncu
- Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Metin Ozkan
- Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey
| | - Irfan Cicin
- Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey
| | | | - Tamer Elkiran
- Inonu University Faculty of Medicine, Malatya, Turkey
| | - Murat Kocer
- Suleyman Demirel University, Isparta, Turkey
| | | | | | | | | | - Arife Ulas
- Education and Research Hospital, Bursa, Turkey
| | - Berna Oksuzoglu
- Ankara Oncology Research and Training Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Feyyaz Ozdemir
- Karadeniz Technical University School of Medicine, Trabzon, Turkey
| | | | - Alper Sevinc
- Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey
| | | | - Mustafa Benekli
- Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
| | - Ruchan Uslu, Ozgur Ozyilkan, Bulent Yalcin, Melih Cem Boruban, Faysal Dane, Oguz Kara, Gamze Gokoz Dogu, Banu Ozturk, Ali Osman Kaya, Mahmut Gumus, Hande Turna
| |
Collapse
|
17
|
Altundag K, Dumanli E, Aliustaoglu M, Uncu D, Ozkan M, Cicin I, Coskun U, Elkiran T, Kocer M, Isikdogan A, Karaoglu A, Tekin SB, Avci N, Ulas A, Oksuzoglu B, Ozdemir F, Kilickap S, Gumus M, Buyukberber S, Benekli M. Turkish National Breast Cancer Registry. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e12654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Kadri Altundag
- Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey
| | | | | | - Dogan Uncu
- Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Metin Ozkan
- Medical Oncology Department, Erciyes University, Kayseri, Turkey
| | - Irfan Cicin
- Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey
| | - Ugur Coskun
- Gazi University Tip Fakultesi, Ankara, Turkey
| | - Tamer Elkiran
- Inonu University Faculty of Medicine, Malatya, Turkey
| | - Murat Kocer
- Suleyman Demirel University, Isparta, Turkey
| | | | | | | | | | - Arife Ulas
- Ali Osman Sonmez Oncology Hospital, Department of Medical Oncology, Bursa, Turkey
| | - Berna Oksuzoglu
- Ankara Oncology Research and Training Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Feyyaz Ozdemir
- Karadeniz Technical University School of Medicine, Trabzon, Turkey
| | | | - Mahmut Gumus
- Kartal Research and Training Hospital, Istanbul, Turkey
| | - Suleyman Buyukberber
- Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
| | - Mustafa Benekli
- Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
| | - Faysal Dane, Alper Sevinc, Melih Cem Boruban, Hande Turna, Ruchan Uslu, Ozgur Ozyilkan, Bulent Yalcin, Oguz Kara, Gamze Gokoz Dogu, Banu Ozturk, Ali Osman Kaya
| |
Collapse
|
18
|
Benekli M, Altundag K, Dumanli E, Isikdogan A, Karaoglu A, Tekin SB, Oksuzoglu B, Kocer M, Sevinc A, Boruban MC, Turna H, Uslu R, Ozyilkan O, Yalcin B, Coskun U, Kilickap S, Dogu GG, Ozturk B, Gumus M, Buyukberber S. Association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e12653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Mustafa Benekli
- Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
| | - Kadri Altundag
- Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey
| | | | | | | | | | - Berna Oksuzoglu
- Ankara Oncology Research and Training Hospital, Department of Medical Oncology, Ankara, Turkey
| | - Murat Kocer
- Suleyman Demirel University, Isparta, Turkey
| | - Alper Sevinc
- Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey
| | - Melih Cem Boruban
- Necmettin Erbakan University Meram Medical Faculty Department of Medical Oncology, Konya, Turkey
| | - Hande Turna
- Istanbul University Cerrahpasa Faculty of Medicine, Department of Oncology, Istanbul, Turkey
| | - Ruchan Uslu
- Ege University School of Medicine, Izmir, Turkey
| | - Ozgur Ozyilkan
- Department of Medical Oncology, Baskent University Faculty of Medicine, Adana, Turkey
| | - Bulent Yalcin
- Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
| | - Ugur Coskun
- Gazi University Tip Fakultesi, Ankara, Turkey
| | | | - Gamze Gokoz Dogu
- Pamukkale University Medical Faculty, Department of Medical Oncology, Kayseri, Turkey
| | - Banu Ozturk
- Department of Medical Oncology, Gaziosmanpasa University Faculty of Medicine, Tokat, Turkey
| | - Mahmut Gumus
- Kartal Research and Training Hospital, Istanbul, Turkey
| | - Suleyman Buyukberber
- Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
| | - Dogan Uncu, Oguz Kara, Mehmet Aliustaoglu, Metin Ozkan, Irfan Cicin, E. Tamer Elkiran, Faysal Dane, Nilufer Avci, Arife Ulas, Feyyaz Ozdemir, Ali Osman Kaya
| |
Collapse
|
19
|
Turkeli M, Aldemir MN, Cayir K, Simsek M, Bilici M, Tekin SB, Yildirim N, Bilen N, Makas I. Efficacy and Tolerability of Weekly Docetaxel, Cisplatin, and 5-Fluorouracil for Locally Advanced or Metastatic Gastric Cancer Patients with ECOG Performance Scores of 1 and 2. Asian Pac J Cancer Prev 2015; 16:985-9. [DOI: 10.7314/apjcp.2015.16.3.985] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
20
|
Yalcin S, Gumus M, Kilickap S, Alkis N, Ilhan M, Oksuzoglu B, Orhan B, Unsal M, Basol Tekin S, Yalcin B, Demir G. End-of-study results of Turkish gastric cancer patients from the global REGATE study. J BUON 2014; 19:377-387. [PMID: 24965395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
PURPOSE Registry of Gastric Cancer Treatment Evaluation (REGATE) study was an international, prospective study including over 10000 patients from 22 countries, designed to describe the pattern of care in gastric cancer globally. The aim of this study was to summarize the data of the Turkish arm and compare them with the global results. METHODS Ten centers from Turkey took part in the REGATE registry. Between 2004 and 2008, 395 patients (median age, 60 years; range, 18-91, 67.6% men) with newly diagnosed primary adenocarcinoma of the stomach were followed at initial visit and 8-10 months later, at the time of treatment completion. Data on patient demographics, medical history, histopathology, cancer stage, planned and realized treatments was prospectively collected. Data processing and analysis were conducted centrally. RESULTS In Turkey, the majority of patients were diagnosed at an advanced stage, while the rate of surgery was lesser compared with the rest of the world. Realized treatment included more palliative-only therapy than initially planned (63.3%), while no therapy was recommended in 21.8%. Surgery involved total gastrectomy (46.3%) or distal subtotal gastrectomy (51.9%), with 87% R0 resection, 51.0% D1 and 44.9% D2 lymph node dissection. Combination chemotherapy was administered in more than half of the patients receiving palliative therapy (57.9%). Chemoradiotherapy was used in 66.7% of the cases receiving adjuvant therapy. Radiotherapy was applied to 32% of the cases receiving palliative therapy. CONCLUSION Advanced stage gastric cancer is highly prevalent in Turkey. Increasing public awareness and implementing screening programs in high risk groups may help identify gastric cancer at earlier stages.
Collapse
Affiliation(s)
- Suayib Yalcin
- Hacettepe University Institute of Oncology, Ankara, Turkey
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Kucukoner M, Arpaci E, Isikdogan A, Bilici M, Uncu D, Cetin B, Dane F, Inanc M, Ekinci AS, Inal A, Cayir K, Yetisyigit T, Ozdemir N, Kaplan MA, Aksoy S, Alkıs N, Tekin SB, Eroglu C, Turhal S, Buyukberber S. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy. Neoplasma 2013; 60:19-25. [PMID: 23067212 DOI: 10.4149/neo_2013_003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The aim of this study is to evaluate the tolerability and toxicity of adjuvant chemoradiotherapy (CRT) and to analyze the prognosis in patients with operable gastric cancer. The retrospective analysis included 723 patients with operable gastric cancer; stage IB-IV (M0), received adjuvant CRT from 8 Medical Centers in Turkey between 2003 and 2010. The patients' age, sex, tumor localization, Lauren classification, grade and stage of the disease, type of dissection, the toxicity and tolerability status and survival rate were analyzed. All patients were divided into two groups as tolerable group to adjuvant CRT and intolerable group to adjuvant CRT .Among the patient, 73.9% had stage III-IVM0 disease; 61.0% had the intestinal type of gastric cancer, 51.1% had the distal type, and 61.4% had undergone D2 dissections. The number of patients who completed the entire course of the adjuvant CRT was 545 (75.4%).The median follow-up period was 20.8 months (range: 1.5-107 months). Overall Survival (OS) rates were 80% and 52%, while the relapse free survival (RFS) rates were 75% and 48% at 1 and 3 years, respectively.In the univariate analysis of the groups based on the the age defined as <65 or ≥ 65 (p=0.16 / p=0.003), Lauren classification (p=0.004 / p<0.001), localization of tumor (p=0.02 / p=0.04), tumor grade (p=0.06 / p=0.003), disease stage (p<0.001 / p<0.001), type of dissection (p=0.445 / p=0.043), presence or absence of toxicity (p=0.062 / p=0.077) and tolerability of the therapy (p=0.002 / p=0.001). In the cox regression analysis, tumor stage (Hazard Ratio (HR): 0.332; 95% confidence interval (CI): 0.195-0.566; p<0.001), and tolerability (HR: 0.516; 95% CI: 0.305-0.872; p=0.014), were found to be related with the OS. Tumor stage (HR: 0.318; 95% CI: 0.190-0.533; p=<0.001) and tolerability (HR: 0.604; 95% CI: 0.367-0.995; p=0.048) were observed to be statistically significant in terms of the RFS.We have observed that whether a patient can or cannot tolerate adjuvant CRT due to its toxicity is an independent prognostic factor besides the known prognostic factors like tumor stage and Lauren classification. We are of the opinion that the treatment of patients who cannot tolerate adjuvant CRT should be replaced with less toxic adjuvant therapies.
Collapse
Affiliation(s)
- M Kucukoner
- Dicle University, Medical Oncology Department, Diyarbakir, Turkey.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Bilici M, Cayir K, Tekin SB, Gundogdu C, Albayrak A, Suleyman B, Ozogul B, Erdemci B, Suleyman H. Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats. Asian Pac J Cancer Prev 2013; 13:4897-900. [PMID: 23244077 DOI: 10.7314/apjcp.2012.13.10.4897] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
OBJECTIVE In this study, anticancer effects of mirtazapine on rats were investigated in an adenocarcinoma model induced by N-methyl-N-nitro-N-nitrosoguanidine (MNNG) and compared with those of cisplatin. MATERIALS AND METHODS For this purpose, 10 mg/kg doses of mirtazapine were administered orally to one group of rats, while 1 mg/kg doses of cisplatin were administered intraperitoneally to another group. At 1 hour after administration, 200 mg/kg doses of MNNG were given orally to both groups. MNNG administration was repeated once every 10 days through 3 months, after which period, gastric tissue was taken and pathologically evaluated. RESULTS Mirtazapine prevented adenocarcinoma induction by MNNG in rats to a greater extent than cisplatin. Some of the rats receiving cisplatin demonstrated severe dysplasia in gastric samples and others exhibited mild dysplasia. Rats given mirtazapine were not observed to suffer severe dysplasia, only mild dysplasia being observed. CONCLUSION For adenocarcinoma induced by MNNG on rats, mirtazapine was determined more effective than cisplatin. In order to make statement about mechanism of anticancer activity of mirtazapine, wider studies are required.
Collapse
Affiliation(s)
- Mehmet Bilici
- Ataturk University, Faculty of Medicine, Erzurum, Turkey.
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Kucukoner M, Arpaci E, Isikdogan A, Bilici M, Uncu D, Cetin B, Dane F, Cayir K, Inanc M, Ekinci AS, Inal A, Yetisyigit T, Ozdemir N, Kaplan MA, Aksoy S, Alkis N, Tekin SB, Eroglu C, Turhal S, Buyukberber S. Prognostic analysis of the patients with operable gastric cancer and the importance of tolerability of therapy: Study of Anatolian Society of Medical Oncology. J Clin Oncol 2012. [DOI: 10.1200/jco.2012.30.15_suppl.e14526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e14526 Background: The aims of this study were to evaluate the tolerability and toxicity with adjuvant chemoradiotherapy (CRT) and prognostic analysis of patients with operable gastric cancer. Methods: The retrospective analysis included 723 patients with operable gastric cancer, stage IB-IV (M0), received adjuvant CRT from 8 Medical Centers in Turkey between 2003 and 2010. Patients’ age, sex, tumor localization, Lauren classification, grade, stage, type of dissection, toxicity and tolerability status were analyzed. Results: 73.9% of the patients were with stage III- IVM0. 61.0% of the patients were in the intestinal type, 51.1% of the patients were with the distal type of gastric cancer and 61.4% of the patients had undergone D2 dissection. 545 (75.4%) of patients completed the entire of adjuvant CRT. The median follow-up period was 20.8 months. Overall Survival (OS) rates were 80% and 52% while relapse free survival (RFS) rates were 75% and 48%, at 1, 3 years, respectively. In univariate analysis of groups, according to the group under the age of 65 and above (p=0.16 / p=0.003), Lauren classification (p=0.004 / p<0.001), localization of tumor (p=0.02 / p=0.04), tumor grade (p=0.06 / p=0.003), stage (p<0.001 / p<0.001), type of dissection (p=0.445 / p=0.043), toxicity (p=0.062 / p=0.077), tolerability of therapy (p=0.002 / p=0.001) were significantly different in both RFS and OS. In multivariate analysis, three independent prognostic factors were identified on RFS / OS; stage (ods ratio (OR)=3.0, 95% confidence interval (CI):1.8-5.0, / OR=3.2, CI=1.8-5.4), for Lauren classification (OR=1.5, CI=0.9-2.2 / OR=1.5, CI= 1.1-2.2), for tolerability of therapy (OR=2.0, CI=1.0-3.8 / OR=1.9, CI=1.0-3.6). Conclusions: We found a new independent prognostic factor whether or not tolerate adjuvant CRT because of toxicity, except for the known prognostic factors like tumor stage and Lauren classification. We suggest that the treatment of the patients with intolerable to adjuvant CRT, is to change with less toxic adjuvant therapies.
Collapse
Affiliation(s)
- Mehmet Kucukoner
- Department of Medical Oncology, Dicle University, Diyarbakir, Turkey
| | | | | | - Mehmet Bilici
- Department of Medical Oncology, Ataturk University, Erzurum, Turkey
| | - Dogan Uncu
- Ankara Numune Training and Research of Medical Oncology, Ankara, Turkey
| | - Bulent Cetin
- Medical Oncology Department of Gazi University, Ankara, Turkey
| | - Faysal Dane
- Department of Medical Oncology, Marmara University, Istanbul, Turkey
| | - Kerim Cayir
- Medical Oncology of Ataturk Universty, Erzurum, Turkey
| | - Mevlude Inanc
- Medical Oncology of Erciyes University, Kayseri, Turkey
| | | | - Ali Inal
- Dicle University Medical Oncology Department, Diyarbakir, Turkey
| | | | | | | | - Sercan Aksoy
- Ankara Numune Training and Research of Medical Oncology, Ankara, Turkey
| | | | | | - Celalettin Eroglu
- Erciyes University, Department of Radiation Oncology , Kayseri, Turkey
| | - Serdar Turhal
- Marmara University Medicine Faculty, Istanbul, Turkey
| | | |
Collapse
|
24
|
Kucukoner M, Isikdogan A, Arpaci E, Bilici M, Uncu D, Cetin B, Dane F, Inane M, Kaplan MA, Cayir K, Yetisyigit T, Ozdemir N, Inal A, Aksoy S, Alkis N, Tekin SB, Eroglu C, Turhal S, Benekli M, Buyukberber S. Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical Oncology. ACTA ACUST UNITED AC 2012; 59:2343-7. [PMID: 22389301 DOI: 10.5754/hge11709] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND/AIMS The aims of this study were to report the clinical outcomes of adjuvant chemo-radiotherapy after curative resection in 637 patients with gastric cancer. METHODOLOGY The retrospective analysis included 637 patients with resectable gastric cancer and stage IB-IV (M0) from 8 medical centers between 2003 and 2010. The patients were treated with 5FU-leucovorin and radiotherapy according to Schema for INT-0116. RESULTS Of the 637 patients, the median of overall survival (OS) was 43.7 months and relapse free survival (RFS) was 36.6 months. OS rates were 84%, 45%, 40% while RFS rates were 81%, 45% and 35% at 1, 3 and 5-years, respectively. Hematological and gastrointestinal toxicities (grade 1-4) were observed in 35% and 36.5% of patients, respectively. In univariate analysis, according to the Lauren classification, tumor grade, T stage, N stage, type of operation (total gastrectomy or subtotal) and surgery resection margin (R0 or R1) were found as prognostic factors on RFS and OS (p<0.05). In multivariate analysis, T stage, N stage and surgical margins were found as effective factors on OS. T stage, N stage and Lauren classification were factors affecting RFS. CONCLUSIONS Adjuvant chemo-radiotherapy after curative resection of gastric cancer was feasible, with acceptable toxicities in the Turkish population.
Collapse
Affiliation(s)
- Mehmet Kucukoner
- Anatolian Society of Medical Oncology Association (ASMO), Turkey.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Bilici M, Ozturk C, Dursun H, Albayrak F, Saglam MB, Uyanik A, Gulaboglu M, Tekin SB. Protective effect of mirtazapine on indomethacin-induced ulcer in rats and its relationship with oxidant and antioxidant parameters. Dig Dis Sci 2009; 54:1868-75. [PMID: 19034656 DOI: 10.1007/s10620-008-0560-z] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2008] [Accepted: 09/26/2008] [Indexed: 01/24/2023]
Abstract
Even though there are many drugs for the treatment of gastric ulcers, these drugs sometimes cannot succeed. Since the 1950s, antidepressant drugs have been used for several non-psychiatric indications. A lot of antidepressant drugs have been shown experimentally to produce antiulcer activity in various ulcer models. This study aimed to investigate the antiulcer effects of mirtazapine and to determine its relationship with antioxidant mechanisms. The antiulcer activities of 15, 30, and 60 mg/kg mirtazapine have been investigated on indomethacin-induced ulcers in rats, and the results have been compared with that of the control group. Mirtazapine decreased the indomethacin-induced ulcers significantly at all doses used. Mirtazapine significantly increased the glutathione (GSH) level, which decreased in the control group given only indomethacin. All doses of mirtazapine significantly decreased the catalase (CAT) level in stomach tissue compared to the control. Additionally, all doses of mirtazapine reversed the decrease in the superoxide dismutase (SOD) level in the stomach tissue of control rats. And finally, all doses of mirtazapine decreased malondialdehyde (MDA) and myeloperoxidase (MPO) levels significantly compared to the control. In conclusion, the activation of enzymatic and non-enzymatic antioxidant mechanisms and the inhibition of some toxic oxidant mechanisms play a role in the antiulcer effect mechanism of mirtazapine. This new indication of mirtazapine will make it the first-choice drug in depressive patients with gastric ulcers.
Collapse
Affiliation(s)
- Mehmet Bilici
- Faculty of Medicine, Department of Internal Medicine, Ataturk University, Erzurum, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Yildirim A, Bilici M, Cayir K, Yanmaz V, Yildirim S, Tekin SB. Serum adiponectin levels in patients with esophageal cancer. Jpn J Clin Oncol 2008; 39:92-6. [PMID: 19116211 DOI: 10.1093/jjco/hyn143] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVE The aim of the study was to investigate a possible relationship between serum levels of adiponectin and clinicopathological characteristics in esophageal cancer. This is the first report evaluating serum adiponectin levels in patients with esophageal cancer. METHODS Sixty-two patients with esophageal cancer and thirty healthy subjects were included in the study. Adiponectin levels were determined by an enzyme-linked immunosorbent assay kit. RESULTS The mean serum adiponectin level in the cancer group was significantly low compared with the adiponectin level in the healthy control group. Furthermore, adiponectin levels of the patients gradually decreased with increase in tumor stage. The patients with adenocarcinoma of the esophagus had significantly lower values of serum adiponectin than patients with squamous cell carcinoma. CONCLUSION We concluded that decreased circulating adiponectin levels may play a role in the progression and/or development of esophageal cancers. However, for clinical use of serum adiponectin in terms of early diagnosis and treatment, further studies should be performed.
Collapse
Affiliation(s)
- Abdulkadir Yildirim
- Department of Biochemistry, Faculty of Medicine, Ataturk Universty, 25240 Erzurum, Turkey.
| | | | | | | | | | | |
Collapse
|
27
|
Abstract
There is currently substantial clinical interest in growth hormone (GH) as a protective agent against radiation-related normal tissue injury. To further assess the potential radiation injury-preventive effects of GH, these effects were studied in rats by using a radiation-induced skin injury model. Group 1 received neither GH nor irradiation (control group). Group 2 received 30 Gy of gamma irradiation as a single dose to the right hind legs of the rats (radiation group). Group 3 and 4 received the same irradiation plus either 0.01 U/kg/day GH (RT + 0.01 GH group) or 0.02 U/kg/day GH (RT + 0.02 GH group) subcutaneously. Clinically and histopathologically, acute skin reactions were assessed by two independent experts in radiation oncology and pathology, respectively. Irradiation increased dermatitis in rats when compared with the control group. The severity of radiodermatitis in the rats in the RT + 0.01 GH and RT + 0.02 GH groups was significantly lower than that in the RT group; radiodermatitis developed earlier in the RT group than in the other groups. GH was efficacious in preventing epidermal atrophy, dermal degeneration such as oedema and collagen fibre loss, and hair follicle atrophy, but not better than in the control group. These results are preliminary to studies that will be performed with higher doses of GH in radiation-treated cancer patients, with the aim of reducing radiation-induced toxicity.
Collapse
Affiliation(s)
- S B Tekin
- Department of Medical Oncology, University Faculty of Medicine, Erzurum, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Ertekin MV, Tekin SB, Erdogan F, Karslioglu I, Gepdiremen A, Sezen O, Balci E, Gündogdu C. The effect of zinc sulphate in the prevention of radiation-induced dermatitis. J Radiat Res 2004; 45:543-548. [PMID: 15635264 DOI: 10.1269/jrr.45.543] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
There is currently substantial clinical interest in zinc (Zn) as a protective agent against radiation-related normal tissue injury. To further assess this drug's potential, the effect of Zn was studied in rats using a radiation-induced skin injury model. Sprague-Dawley rats were divided into four groups. Group 1 received neither Zn nor irradiation (control group). Group 2 received 30 Gy of gamma irradiation as a single dose to the right hind legs of the rats (RT Group). Groups 3 and 4 received the same irradiation plus 5 mg/kg/day Zn (RT+5 Zn group) or 10 mg/kg/day Zn orally (RT+10 Zn group), respectively. The rats were irradiated using a cobalt-60 teletherapy unit. Acute skin reactions were assessed every three days by two independent radiation oncology experts. At the endpoint of the study, light-microscopic findings were assessed by two independent expert pathology physicians. Clinically and histopathologically, irradiation increased dermatitis when compared with the control group (p < 0.05). The severity of radiodermatitis of the rats in the RT+5 Zn and RT+10 Zn groups was significantly lower than in the RT group (p < 0.05); radiodermatitis was seen earlier in the RT group than in the other groups (p < 0.05). Zn was found to be efficacious in preventing epidermal atrophy, dermal degeneration such as edema and collagen fiber loss, and hair follicle atrophy. The most protection for radiation dermatitis was observed in the RT+10 Zn group. It would be worthwhile studying the effects of zinc sulphate supplements in radiation-treated cancer patients, in the hope of reducing radiation-induced toxicity.
Collapse
Affiliation(s)
- Mustafa Vecdi Ertekin
- Department of Radiation Oncology, Atatürk University Faculty of Medicine, Erzurum, Turkey.
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Akçay MN, Tekin SB, Akçay G. Addisonian crisis due to adrenal gland metastasis in Hodgkin's disease. Int J Clin Pract 2003; 57:840-1. [PMID: 14686577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
Abstract
Adrenal insufficiency or Addison's disease is a rare illness associated with multiple pathology. We describe the case of a 61-year-old male with Hodgkin's disease and metastases in both adrenal glands who was diagnosed with adrenal insufficiency as a result of an acute addisonian crisis.
Collapse
Affiliation(s)
- M N Akçay
- Department of General Surgery, University of Atatürk School of Medicine, Erzurum, Turkey
| | | | | |
Collapse
|
30
|
Abstract
We report the case of recurrent myocardial infarction with essential thrombocythemia (ET) in a 61-year-old female patient. Only one report of recurrence of myocardial infarction has been previously described. Coronary angiography 10 days after the infarction was normal. Thrombocythemia had been controlled with hydroxyurea.
Collapse
Affiliation(s)
- H Kaya
- Department of Haematology, University of Atatürk, Erzurum, Turkey
| | | | | | | | | |
Collapse
|
31
|
Tonbul HZ, Kaya H, Selçuk NY, Tekin SB, San A, Akçay F, Akarsu E. The importance of serum transferrin receptor level in the diagnosis of functional iron deficiency due to recombinant human erythropoietin treatment in haemodialysis patients. Int Urol Nephrol 1999; 30:645-51. [PMID: 9934812 DOI: 10.1007/bf02550560] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
In haemodialysis (HD) patients, functional iron deficiency frequently appears due to recombinant human erythropoietin (r-HuEPO) treatment. However, the diagnosis of iron deficiency is not always easy in such patients. Recent studies have shown that the serum transferrin receptor (s-TfR) level is a sensitive, quantitative measure of tissue iron deficiency. In this study, we examined the changes in s-TfR levels in patients with iron deficiency anaemia due to r-HuEPO treatment. We compared s-TfR levels of 24 patients with i.v. administered r-HuEPO (50-70 U/kg/dose) at the end of each dialysis session (three times a week) and diagnosed as having iron deficiency anaemia by routine laboratory methods (ferritin <50 microg/l and transferrin saturation <16%) with s-TfR levels of 32 patients not receiving r-HuEPO and without iron deficiency anaemia. Also, 40 healthy volunteer subjects were included in the study as a control group. Serum ferritin and transferrin receptor levels were measured with ELISAs using monoclonal reagents. There were no differences between the two groups with and without iron deficiency anaemia with respect to mean age, body weight, haemodialysis duration, haemoglobin and serum creatinine levels (p>0.05). For s-TfR levels, while no difference was present between the control and the non-iron deficiency groups (p>0.05), the iron deficiency group had higher s-TfR values than those of both the control and non-iron deficiency groups (p<0.001). Besides, there was an inverse correlation between haemoglobin and s-TfR levels in patients with iron deficiency anaemia (r = -0.85, p<0.0001). We conclude that the measurement of s-TfR levels may be useful in the diagnosis of functional iron deficiency in haemodialysis patients receiving r-HuEPO.
Collapse
Affiliation(s)
- H Z Tonbul
- Department of Nephrology, Medical Faculty, Atatürk University, Erzurum, Turkey
| | | | | | | | | | | | | |
Collapse
|
32
|
Zeki Tonbul H, Kaya H, Selçuk Y, San A, Akçay F, Tekin SB. Serum transferrin receptor level in the diagnosis of iron deficiency due to erythropoietin treatment. Nephron Clin Pract 1998; 80:241. [PMID: 9736832 DOI: 10.1159/000045179] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Affiliation(s)
- H Zeki Tonbul
- Department of Nephrology, Faculty of Medicine, Atatürk University, Erzurum, Turkey
| | | | | | | | | | | |
Collapse
|
33
|
Akçay G, Uslu H, Varoglu E, Tekin SB, Gündogdu C. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy. Br J Clin Pract 1997; 51:5-7. [PMID: 9158263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Thyroid nodularity is a common finding. The incidence of thyroid cancer in the general population is estimated at 0.1%. Thyroid nodules are evaluated by palpation, ultrasonography, radionuclide scintigraphy and fine-needle aspiration cytology. Routine thyroid scintigraphy is made by using Tc-99m-pertechnetate or the I-131 and I-123 scintigraphic method. Tc-99m-tetrofosmin accumulates in the myocardium, skeletal muscle, liver, spleen breast tissue, kidney and normal and pathological thyroid tissue. We investigated 36 patients (28 females and 8 males) with solitary and/or multiple thyroid nodules. All the patients were euthyroid, and their thyroid nodules were diagnosed by palpation and ultrasound examination. Thyroid scintigraphy was applied by Tc-99m-pertechnetate, then thyroid fine-needle aspiration biopsy was performed. Finally, Tc-99m-tetrofosmin scintigraphy was carried out. Five patients (14.8%) had differential thyroid carcinoma, 23 (63.8%) had thyroid adenoma, 1 (0.02%) had Riedel's thyroiditis and 7 (19.4%) had follicular cyst. We detected 80% uptake in the early phase and 100% in the late phase by Tc-99m-tetrofosmin scintigraphy in the differentiated thyroid carcinoma group. In summary, we claim that Tc-99m-tetrofosmin may be an important scintigraphic method to identify thyroid malignancy from benign thyroid pathologies.
Collapse
Affiliation(s)
- G Akçay
- Division of Endocrinology, Department of Internal Medicine, University of Atatürk, Erzurum, Turkey
| | | | | | | | | |
Collapse
|
34
|
Selçuk NY, San A, Tonbul Z, Gündoğdu M, Tekin SB. Effects of a normalized protein catabolism rate on platelet functions in non-dialyzed uraemic patients. Nephron Clin Pract 1995; 70:141-2. [PMID: 7617111 DOI: 10.1159/000188575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
|